Endogenous inhibitory mechanisms in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 3 II, 2000, Pages

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; CARBON MONOXIDE; CYTOKINE; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; LIPOXIN; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA;

ASTHMA; CHRONIC INFLAMMATION; CONFERENCE PAPER; CYTOKINE RELEASE; HUMAN; IMMUNOMODULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0034108146     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.supplement_2.a1q4-6     Document Type: Conference Paper

References (71)

1. Barnes, P. J., K. F. Chung, and C. P. Page. 1998. Inflammatory mediators of asthma: an update. Pharmacol. Rev. 50:515-596.
2. Barnes, P. J., and S. Lim. 1998. Inhibitory cytokines in asthma. Mol. Med. Today 4:452-458.
3. Sasaki, H., M. Yanai, S. Shimura, H. Okayama, T. Aikawa, T. Sasaki, and T. Takishima. 1987. Late asthmatic response to Ascaris antigen challenge in dogs treated with metyrapone. Am. Rev. Respir. Dis. 136: 1459-1465.
4. Herrscher, R. F., C. Kasper, and T. J. Sullivan. 1992. Endogenous cortisol regulates immunoglobulin E-dependent late phase reactions. J. Clin. Invest. 90:593-603.
5. Schleimer, R. P. 1991. Potential regulation of inflammation in the lung by local metabolism of hydrocortisone. Am. J. Respir. Cell Mol. Biol. 4:166-173.
6. Pavord, I. D., and A. E. Tattersfield. 1995. Bronchoprotective role for endogenous prostaglandin E2. Lancet 344:436-438.
7. 2 on exercise-induced broncho-constriction in asthmatic subjects. Am. J. Respir. Crit. Care Med. 149: 1138-1141.
8. Pavord, I. D., C. S. Wong, J. Williams, and A. E. Tattersfield. 1993. Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am. Rev. Respir. Dis. 148:87-90.
9. Mitchell, J. A., M. G. Belvisi, P. Akarasereemom, R. A. Robbins, O. J. Kowon, J. Croxtell, P. J. Barnes, and J. R. Vane. 1994. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br. J. Pharmacol. 113:1008-1014.
10. 2 release by intact cells expressing cyclooxygenase-2: evidence for a "two-component" model. J. Pharmacol. Exp. Ther. 288:1101-1106.
11. 4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J. Immunol. 156:2264-2272.
12. 4: a novel anti-inflammatory molecule? Thorax 50:111-112.
13. Martinez, A., M. J. Miller, E. J. Unsworth, J. M. Siegfried, and F. Cuttitta. 1995. Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology 136:4099-4105.
14. Kanazawa, H., N. Kurihara, K. Hirata, S. Kudo, T. Kawaguchi, and T. Takeda. 1994. Adrenomedullin, a newly discovered hypotensive peptide, is a potent bronchodilator. Biochem. Biophys. Res. Commun. 205:251-254.
15. Kubo, A., N. Minamino, Y. Isumi, T. Katafuchi, K. Kangawa, K. Dohi, and H. Matsuo. 1998. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J. Biol. Chem. 273:16730-16738.
16. Kamoi, H., H. Kanazawa, K. Hirata, N. Kurihara, Y. Yano, and S. Otani. 1995. Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem. Biophys. Res. Commun. 211:1031-1035.
17. Said, S. I. 1990. Neuropeptides as modulators of injury and inflammation. Life Sci. 47:PL19-PL20.
18. Ollerenshaw, S., D. Jarvis, A. Wookcock, C. Sullivan, and T. Scheibner. 1989. Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N. Engl. J. Med. 320: 1244-1248.
19. Lilly, C. M., T. R. Bai, S. A. Shore, A. E. Hall, and J. M. Drazen. 1995. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am. J. Respir. Crit. Care Med. 151:548-553.
20. Howarth, P. H., D. R. Springall, A. E. Redington, R. Djukanovic, S. T. Holgate, and J. M. Polak. 1995. Neuropeptide-containing nerves in bronchial biopsies from asthmatic and non-asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 13:288-296.
21. Barnes, P. J. 1995. Nitric oxide and airway disease. Ann. Med. 27:389-393.
22. Barnes, P. J. 1996. NO or no NO in asthma? Thorax 51:218-220.
23. Bernareggi, M., J. A. Mitchell, P. J. Barnes, and M. G. Belvisi. 1997. Dual action of nitric oxide on airway plasma leakage. Am. J. Respir. Crit. Care Med. 155:869-874.
24. Yates, D. H., S. A. Kharitonov, M. Worsdell, P. S. Thomas, and P. J. Barnes. 1996. Exhaled nitric oxide is decreased after inhalation of a specific inhibitor of inducible nitric oxide synthase, in asthmatic but not in normal subjects. Am. J. Respir. Crit. Care Med. 154:247-250.
25. Taylor, D. A., J. L. McGrath, L. M. Orr, P. J. Barnes, and B. J. O'Connor. 1998. Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5′-monophosphate in asthma. Thorax 53:483-489.
26. Taylor, D. A., J. L. McGrath, B. J. O'Connor, and P. J. Barnes. 1998. Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide. Am. J. Respir. Crit. Care Med. 157:99-106.
27. Zayasu, K., K. Sekizawa, S. Okinaga, M. Yamaya, T. Ohrui, and H. Sasaki. 1997. Increased carbon monoxide in exhaled air of asthmatic patients. Am. J. Respir. Crit. Care Med. 156:1140-1143.
28. Horvath, I., L. E. Donnelly, A. Kiss, P. Paredi, S. A. Kharitonov, and P. J. Barnes. 1998. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 53: 668-672.
29. Willis, D., A. R. Moore, R. Frederick, and D. A. Willoughby. 1996. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nature Med. 2:87-90.
30. Otterbein, L. E., L. L. Mantell, and A. M. Choi. 1999. Carbon monoxide provides protection against hyperoxic lung injury. Am. J. Physiol. 276:L688-L694.
31. Ho, A. S., and K. W. Moore. 1994. Interleukin-10 and its receptor. Ther. Immunol. 1:173-185.
32. Pretolani, M., and M. Goldman. 1997. IL-10: a potential therapy for allergic inflammation? Immunol. Today 18:277-280.
33. Kline, J. N., P. A. Fisher, M. M. Monick, and G. W. Hunninghake. 1995. Regulation of interleukin-1 receptor antagonist by Th1 and Th2 cytokines. Am. J. Physiol. 269:L92-L98.
34. Arock, M., C. Zuany-Amorim, M. Singer, M. Benhamou, and M. Pretolani. 1996. Interleukin-10 inhibits cytokine generation from mast cells. Eur. J. Immunol. 26:166-170.
35. John, M., S. J. Hirst, P. Jose, A. Robichaud, C. Witt, C. Twort, N. Berkman, P. J. Barnes, and K. F. Chung. 1997. Human airway smooth muscle cells express and release RANTES in response to Th1 cytokines: regulation by Th2 cytokines. J. Immunol. 158:1841-1847.
36. Takanaski, S., R. Nonaka, Z. Xing, P. O'Byrne, J. Dolovich, and M. Jordana. 1994. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood cosinophils. J. Exp. Med. 180:711-715.
37. Spencer, S. D., F. Di Marco, J. Hooley, S. Pitts-Meek, M. Bauer, A. M. Ryan, B. Sordat, V. C. Gibbs, and M. Aguet. 1998. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J. Exp. Med. 187:571-578.
38. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah. 1995. Interleukin (IL)-10 inhibits nuclear factor kappa B activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270:9558-9563.
39. Zuany-Amorim, C., S. Haile, D. Leduc, C. Dumarey, M. Huerre, B. B. Vargaftig, and M. Pretolani. 1995. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J. Clin. Invest. 95:2644-2651.
40. Borish, L., A. Aarons, J. Rumbyrt, P. Cvietusa, J. Negri, and S. Wenzel. 1996. Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol. 97:1288-1296.
41. John, M., S. Lim, J. Seybold, A. Robichaud, B. O'Connor, P. J. Barnes, and K. F. Chung. 1998. Inhaled corticosteroids increase IL-10 but reduce MIP-1α, GM-CSF and IFN-γ release from alveolar macrophages in asthma. Am. J. Respir. Crit. Care Med. 157:256-262.
42. Spiteri, M. A., R. A. Knight, J. Y. Jeremy, P. J. Barnes, and K. F. Chung. 1994. Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. Eur. Respir. J. 7:1431-1438.
43. Turner, D. M., D. M. Williams, D. Sankaran, M. Lazarus, P. J. Sinnott, and I. V. Hutchinson. 1997. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 24:1-8.
44. Lim, S., E. Crawley, P. Woo, and P. J. Barnes. 1998. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 352:113.
45. Arend, W. P. 1991. Interleukin 1 receptor antagonist: a new member of the interleukin 1 family. J. Clin. Invest. 88:1445-1451.
46. Sim, T. C., K. A. Hilsmeier, L. M. Reece, J. A. Grant, and R. Alam. 1994. Interleukin-1 receptor antagonist protein inhibits the synthesis of IgE and proinflammatory cytokines by allergen-stimulated mononuclear cells. Am. J. Respir. Cell Mol. Biol. 11:473-479.
47. Sousa, A. R., S. J. Lane, J. A. Nakhosteen, T. H. Lee, and R. N. Poston. 1996. Expression of interleukin-Iβ (IL-1β) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am. J. Respir. Crit. Care Med. 154:1061-1066.
48. Okada, S., H. Inoue, K. Yamauchi, H. Iijima, Y. Ohkawara, T. Takishima, and K. Shirato. 1995. Potential role of interleukin-1 in allergen-induced late asthmatic reactions in guinea pigs: suppressive effect of interleukin-1 receptor antagonist on late asthmatic reaction. J. Allergy Clin. Immunol. 95:1236-1245.
49. Coyle, A. J., S. Tsuyuki, C. Bertrand, S. Huang, M. Aguet, S. S. Alkan, and G. P. Anderson. 1996. Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung cosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J. Immunol. 156:2680-2685.
50. Leonard, C., V. Tormey, T. Burke, and L. W. Poulter. 1997. Allergen-induced cytokine production in atopic disease and its relationship to disease severity. Am. J. Respir. Cell Mol. Biol. 17:368-375.
51. Koning, H., H. J. Neijens, M. R. Baert, A. P. Oranje, and H. F. Savelkoul. 1997. T cell subsets and cytokines in allergic and non-allergic children: I. Analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production. Cytokine 9:416-426.
52. Hayden, C., E. Pereira, P. Rye, L. Palmer, N. Gibson, M. Palenque, I. Hagel, N. Lynch, J. Goldblatt, and P. Lesouef. 1997. Mutation screening of interferon-γ (IFNγ) as a candidate gene for asthma. Clin. Exp. Allergy 27:1412-1416.
53. Boguniewicz, M., R. J. Martin, D. Martin, U. Gibson, and A. Celniker. 1995. The effects of nebulized recombinant interferon-γ in asthmatic airways. J. Allergy Clin. Immunol. 95:133-135.
54. Lack, G., H. S. Nelson, D. Amran, A. Oshiba, T. Jung, K. L. Bradley, P. C. Giclas, and F. W. Gelfand. 1997. Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells. J. Allergy Clin. Immunol. 99:530-538.
55. Hamid, Q. A., E. Schotman, M. R. Jacobson, S. M. Walker, and S. R. Durham. 1997. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J. Allergy Clin. Immunol. 99:254-260.
56. Gately, M. K., L. M. Renzetti, J. Magram, A. S. Stern, L. Adorini, U. Gubler, and D. H. Presky. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:495-521; 495-521.
57. Kips, J. C., G. J. Brusselle, G. F. Joos, R. A. Peleman, J. H. Tavernier, R. R. Devos, and R. A. Pauwels. 1996. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 153:535-539.
58. Wills-Karp, M. 1998. Interleukin-12 as a target for modulation of the inflammatory response. Allergy 53:113-119.
59. Sur, S., J. Lam, P. Bouchard, A. Sigounas, D. Holbert, and W. J. Metzger. 1996. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J. Immunol. 157:4173-4180.
60. Bruselle, G. G., J. C. Kips, R. A. Peleman, G. F. Joos, R. R. Devos, J. H. Tavernier, and R. A. Pauwels. 1997. Role of IFN-gamma in the inhibition of the allergic airway inflammation caused by IL-12. Am. J. Respir. Cell Mol. Biol. 17:767-771.
61. van der Pouw Kraan, T. C., L. C. Bocije, E. R. de Groot, S. O. Stapel, A. Snijders, M. L. Kapsenberg, J. S. van der Zee, and L. A. Aarden. 1997. Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma. J. Immunol. 158:5560-5565.
62. Naseer, T., E. M. Minshall, D. Y. Leung, S. Laberge, P. Ernst, R. J. Martin, and Q. Hamid. 1997. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroids. Am. J. Respir. Crit. Care Med. 155:845-851.
63. Blotta, M. H., R. H. DeKruyff, and D. T. Umetsu. 1997. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J. Immunol. 158:5589-5595.
64. Panina-Bordignon, P., D. Mazzeo, P. D. Lucia, D. D'Ambrosio, R. Lang, L. Fabbri, C. Self, and F. Sinigaglia. 1997. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100:1513-1519.
65. Kohno, K., and M. Kurimoto. 1998. Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clin. Immunol. Immunopathol. 86:11-15.
66. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S. B. Hartley, S. Menon, R. Kastelein, F. Bazan, and A. O'Garra. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 7:571-581.
67. Yoshimoto, T., H. Okamura, Y. I. Tagawa, Y. Iwakura, and K. Nakanishi. 1997. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc. Natl. Acad. Sci. U.S.A. 94:3948-3953.
68. Puren, A. J., G. Fantuzzi, Y. Gu, M. S. Su, and C. A. Dinarello. 1998. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1β via TNFα production from non-CD14+ human blood mononuclear cells. J. Clin. Invest. 101:711-721.
69. Berkman, N., M. John, G. Roesens, P. Jose, P. J. Barnes, and K. F. Chung. 1996. Interleukin 13 inhibits macrophage inflammatory protein-1α production from human alveolar macrophages and monocytes. Am. J. Respir. Cell Mol. Biol. 15:382-389.
70. Berkman, N., A. Rohichaud, R. A. Robbins, G. Roesems, E.-B. Haddad, P. J. Barnes, and K. F. Chung. 1996. Inhibition of inducible nitric oxide synthase in a human bronchial epithelial cell line by IL-4 and IL-13. Immunology 89:363-367.
71. Spahn, J. D., S. J. Szefler, W. Surs, D. E. Doherty, S. R. Nimmagadda, and D. Y. Leung. 1996. A novel action of IL-13: induction of diminished monocyte glucorticoid receptor-binding affinity. J. Immunol. 157:2654-2659.